Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1980 4
1983 1
1985 1
1986 1
1987 2
1988 2
1989 1
1990 4
1991 7
1992 5
1993 1
1994 4
1995 5
1996 1
1997 5
1998 4
1999 8
2000 7
2001 5
2002 9
2003 5
2004 5
2005 6
2006 13
2007 11
2008 18
2009 6
2010 14
2011 11
2012 13
2013 13
2014 16
2015 15
2016 14
2017 13
2018 6
2019 2
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Results by year
Filters applied: . Clear all
Page 1
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.
Medico E, Russo M, Picco G, Cancelliere C, Valtorta E, Corti G, Buscarino M, Isella C, Lamba S, Martinoglio B, Veronese S, Siena S, Sartore-Bianchi A, Beccuti M, Mottolese M, Linnebacher M, Cordero F, Di Nicolantonio F, Bardelli A. Medico E, et al. Among authors: mottolese m. Nat Commun. 2015 Apr 30;6:7002. doi: 10.1038/ncomms8002. Nat Commun. 2015. PMID: 25926053 Free article.
TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment.
Zizza P, Dinami R, Porru M, Cingolani C, Salvati E, Rizzo A, D'Angelo C, Petti E, Amoreo CA, Mottolese M, Sperduti I, Chambery A, Russo R, Ostano P, Chiorino G, Blandino G, Sacconi A, Cherfils-Vicini J, Leonetti C, Gilson E, Biroccio A. Zizza P, et al. Among authors: mottolese m. Nucleic Acids Res. 2019 Apr 23;47(7):3365-3382. doi: 10.1093/nar/gkz041. Nucleic Acids Res. 2019. PMID: 30698737 Free PMC article.
TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients.
Dinami R, Porru M, Amoreo CA, Sperduti I, Mottolese M, Buglioni S, Marinelli D, Maugeri-Saccà M, Sacconi A, Blandino G, Leonetti C, Di Rocco G, Verdina A, Spinella F, Fiorentino F, Ciliberto G, Biroccio A, Zizza P. Dinami R, et al. Among authors: mottolese m. J Exp Clin Cancer Res. 2020 Jun 15;39(1):111. doi: 10.1186/s13046-020-01612-z. J Exp Clin Cancer Res. 2020. PMID: 32539869 Free PMC article.
Androgen receptor and antiandrogen therapy in male breast cancer.
Di Lauro L, Barba M, Pizzuti L, Vici P, Sergi D, Di Benedetto A, Mottolese M, Speirs V, Santini D, De Maria R, Maugeri-Saccà M. Di Lauro L, et al. Among authors: mottolese m. Cancer Lett. 2015 Nov 1;368(1):20-25. doi: 10.1016/j.canlet.2015.07.040. Epub 2015 Aug 11. Cancer Lett. 2015. PMID: 26276719 Free article. Review.
Triple positive breast cancer: a distinct subtype?
Vici P, Pizzuti L, Natoli C, Gamucci T, Di Lauro L, Barba M, Sergi D, Botti C, Michelotti A, Moscetti L, Mariani L, Izzo F, D'Onofrio L, Sperduti I, Conti F, Rossi V, Cassano A, Maugeri-Saccà M, Mottolese M, Marchetti P. Vici P, et al. Among authors: mottolese m. Cancer Treat Rev. 2015 Feb;41(2):69-76. doi: 10.1016/j.ctrv.2014.12.005. Epub 2014 Dec 19. Cancer Treat Rev. 2015. PMID: 25554445 Free article. Review.
Cancer stem cells: are they responsible for treatment failure?
Maugeri-Saccà M, Vici P, Di Lauro L, Barba M, Amoreo CA, Gallo E, Mottolese M, De Maria R. Maugeri-Saccà M, et al. Among authors: mottolese m. Future Oncol. 2014 Oct;10(13):2033-44. doi: 10.2217/fon.14.126. Future Oncol. 2014. PMID: 25396775 Review.
242 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page